| 今开：0.3949 | 昨收：0.3925 |
| 最高：0.3949 | 最低：0.367 |
| 涨停价：0.0 | 跌停价：0.0 |
| 总市值：2325135.0 |
Galmed(GLMD)03-20 04:35
$Galmed(GLMD)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001493152-24-010476 Act: 34 Size: 16 KB 网页链接查看全文
Galmed(GLMD)02-14 22:55
$Galmed(GLMD)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0000921895-24-000447 Act: 34 Size: 266 KB 网页链接查看全文
Galmed(GLMD)02-13 05:25
$Galmed(GLMD)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0001493152-24-005902 Act: 34 Size: 97 KB 网页链接查看全文
Galmed(GLMD)03-15 21:15
$Galmed(GLMD)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001493152-24-010019 Act: 34 Size: 32 KB 网页链接查看全文
Galmed(GLMD)04-05 05:05
$Galmed(GLMD)$ 20-F Annual and transition report of foreign private issuers [Sections 13 or 15(d)] Accession Number: 0001493152-24-013203 Act: 34 Size: 9 MB 网页链接查看全文
Galmed(GLMD)02-15 03:25
$Galmed(GLMD)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0001104659-24-023435 Act: 34 Size: 61 KB 网页链接查看全文
F1watch2023-07-14 05:20
F-1/A - Galmed Pharmaceuticals Ltd. (0001595353) (Filer) Filed: 2023-07-13 AccNo: 0001493152-23-024507 Size: 822 KB 网页链接查看全文
F1watch2023-07-13 05:40
F-1/A - Galmed Pharmaceuticals Ltd. (0001595353) (Filer) Filed: 2023-07-12 AccNo: 0001493152-23-024354 Size: 1 MB 网页链接查看全文
F1watch2023-06-28 20:40
F-1/A - Galmed Pharmaceuticals Ltd. (0001595353) (Filer) Filed: 2023-06-28 AccNo: 0001493152-23-022693 Size: 1 MB 网页链接查看全文
F1watch2023-06-17 04:20
F-1 - Galmed Pharmaceuticals Ltd. (0001595353) (Filer) Filed: 2023-06-16 AccNo: 0001493152-23-021672 Size: 1 MB 网页链接查看全文
蹊之美股生物医药2021-11-02 22:10
作者：王医生
微信公众号：蹊之美股生物医药 / CaesarBiotech
标的公司：Galmed Pharmaceuticals Ltd.（NASDAQ：GLMD）
Galmed Pharmaceuticals Ltd. (Nasdaq: GLMD)是一家临床阶段的肝脏、代谢和炎症疾病生物制药公司，今天宣布了ARMOR 3期研究开放标签部分的前16名患者接受预定的...查看全文
蹊之美股生物医药2021-08-03 23:10
Gainers:
Infinity Pharmaceuticals (NASDAQ:INFI)+38%
Exicure (NASDAQ:XCUR) +34%
Ra Medical Systems (NYSE:RMED) +18%
Galmed Pharmaceuticals (NASDAQ:GLMD) +17%
Lava Therapeutics (NASDAQ:LVTX) +5%
Losers:
Immunovant (NASDAQ:IMVT) -26%...查看全文
美通社2021-04-03 23:45
中国苏州和美国马里兰州罗克维尔市2021年4月2日 /美通社/ -- 致力于在肿瘤、乙肝及与衰老相关疾病等治疗领域开发创新药物的处于临床阶段的研发企业——亚盛医药（6855.HK）日前宣布，公司任命知名肿瘤学专家David Sidransky博士为独立非执行董事，该任命自2021年3月31日起生效。
Sidransky博士...查看全文
洛其飞2021-02-15 11:50
$Galmed(GLMD)$ 目前全球领先的NASH新药研发公司，如果今年能第一家取得FDA该类新药的审批，妥妥超过nvax去年的涨幅，持续关注nash类新药研发进展。查看全文
$Galmed(GLMD)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0001493152-23-003842 Act: 34 Size: 99 KB 网页链接
$Galmed(GLMD)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001493152-23-000619 Act: 34 Size: 22 KB 网页链接
$Galmed(GLMD)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001493152-23-000217 Act: 34 Size: 45 KB 网页链接
$Galmed(GLMD)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001493152-22-035461 Act: 34 Size: 42 KB 网页链接
$Galmed(GLMD)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001493152-22-032644 Act: 34 Size: 244 KB 网页链接
$Galmed(GLMD)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001493152-22-021243 Act: 34 Size: 1 MB 网页链接
$Galmed(GLMD)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001493152-22-018756 Act: 34 Size: 57 KB 网页链接
$Galmed(GLMD)$ 424B5 Prospectus [Rule 424(b)(5)] Accession Number: 0001493152-22-018384 Act: 33 Size: 20 KB 网页链接
$Galmed(GLMD)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001493152-22-018111 Act: 34 Size: 16 KB 网页链接
$Galmed(GLMD)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001493152-22-017511 Act: 34 Size: 15 KB 网页链接